VBL Therapeutics Announces Third Quarter 2018 Financial Results
TEL AVIV, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced financial results for the third quarter ended September 30, 2018 and provided a corporate update. “We continue the development of our novel anticancer drug …